Recent developments in the treatment of bladder cancer

被引：0
作者：
Lance, RS [1 ]
Grossman, HB [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
来源：
BLADDER DISEASE: RESEARCH CONCEPTS AND CLINICAL APPLICATIONS, PTS A AND B | 2003年 / 539卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：3 / 14
页数：12
相关论文
共 60 条
[1]   BCG immunotherapy of bladder cancer: 20 years on [J].
Alexandroff, AB ;
Jackson, AM ;
O'Donnell, MA ;
James, K .
LANCET, 1999, 353 (9165) :1689-1694
[2]  
[Anonymous], 1999, Lancet, V354, P533
[3]  
BADALAMENT RA, 1987, CANCER, V60, P1423, DOI 10.1002/1097-0142(19871001)60:7<1423::AID-CNCR2820600702>3.0.CO
[4]  
2-6
[5]  
Bastacky S, 1999, CANCER CYTOPATHOL, V87, P118, DOI 10.1002/(SICI)1097-0142(19990625)87:3<118::AID-CNCR4>3.0.CO
[6]  
2-N
[7]  
Bonner RB, 1996, CANCER EPIDEM BIOMAR, V5, P971
[8]   LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH 1 OR 2, 6-WEEK COURSES OF INTRAVESICAL BACILLUS CALMETTE-GUERIN - ANALYSIS OF POSSIBLE PREDICTORS OF RESPONSE FREE OF TUMOR [J].
COPLEN, DE ;
MARCUS, MD ;
MYERS, JA ;
RATLIFF, TL ;
CATALONA, WJ .
JOURNAL OF UROLOGY, 1990, 144 (03) :652-657
[9]  
CordonCardo C, 1997, CANCER RES, V57, P1217
[10]   PHASE-IIA STUDY OF FENRETINIDE IN SUPERFICIAL BLADDER-CANCER, USING DNA FLOW-CYTOMETRY AS AN INTERMEDIATE END-POINT [J].
DECENSI, A ;
BRUNO, S ;
COSTANTINI, M ;
TORRISI, R ;
CUROTTO, A ;
GATTESCHI, B ;
NICOLO, G ;
POLIZZI, A ;
PERLOFF, M ;
MALONE, WF ;
BRUZZI, P .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (02) :138-140
123456